Division of Sports and Space Physiology

1.

Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.

doi DEA Scopus

Journal metrics:

D1 Medicine (miscellaneous) (2024)

D1 Pharmacology (2024)

2.

Kovács, Z. M., Horváth, B., Dienes, C., Óvári, J., Kiss, D. Z., Hézső, T., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Beta-Adrenergic Activation of the Inward Rectifier K+ Current Is Mediated by the CaMKII Pathway in Canine Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 25 (21), 1-14, (article identifier: 11609), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

3.

Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.

doi DEA WoS Scopus

4.

Horváth, B., Kovács, Z. M., Dienes, C., Barta, Z., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Relationship between ion currents and membrane capacitance in canine ventricular myocytes.
Sci. Rep. 14 (1), 11241, (article identifier: 11241), 2024.

doi DEA Scopus

Journal metrics:

Q1 Multidisciplinary

5.

Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr.
Pharmaceuticals (Basel). 16 (4), 488, (article identifier: 488), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

6.

Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Conductance Changes of Na+ Channels during the Late Na+ Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes.
Pharmaceuticals (Basel). 16 (4), 560, (article identifier: 560), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

7.

Naveed, M., Mohammed, A. S. A., Topal, L., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Prorok, J., Jost, N., Virág, L., Baczkó, I., Varró, A., Nánási, P. P., Horváth, B.: Selective Inhibition of Cardiac Late Na+ Current Is Based on Fast Offset Kinetics of the Inhibitor.
Biomedicines. 11 (9), 2383, (article identifier: 2383), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

8.

Gaál, Z., Fodor, J., Oláh, A., Radovits, T., Merkely, B., Magyar, J., Csernoch, L.: Evaluation of muscle-specific and metabolism regulating microRNAs in a chronic swimming rat model.
J. Muscle Res. Cell Motil. 43 (1), 21-33, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q2 Cell Biology

Q1 Physiology

9.

Kovács, Z. M., Dienes, C., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: modulation of TRPM4.
Pharmaceuticals (Basel). 15 (1), 81, (article identifier: 81), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

10.

Dienes, C., Kovács, Z. M., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.
Pharmaceuticals (Basel). 15 (1), 40, (article identifier: 40), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

11.

Kiss, D. Z., Hézső, T., Dienes, C., Kovács, Z. M., Török, Z., Szentandrássy, N., Horváth, B., Bányász, T., Nánási, P. P., Magyar, J.: Calcium/calmodulin-dependent protein kinase II stimulates the inward rectifier potassium current in beta-adrenergic adaptation of ventricular cardiomyocytes.
Europace. 23 (Suppl.), iii634, 2021.

doi DEA

12.

Dienes, C., Hézső, T., Kiss, D. Z., Baranyai, D., Kovács, Z. M., Szabó, L., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Gönczi, M., Szentandrássy, N.: Electrophysiological Effects of the Transient Receptor Potential Melastatin 4 Channel Inhibitor (4-Chloro-2-(2-chlorophenoxy)acetamido) Benzoic Acid (CBA) in Canine Left Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 22 (17), 9499, (article identifier: 9499), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

13.

Horváth, B., Kiss, D. Z., Dienes, C., Hézső, T., Kovács, Z. M., Szentandrássy, N., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P.: Ion current profiles in canine ventricular myocytes obtained by the "onion peeling" technique.
J. Mol. Cell. Cardiol. 158, 153-162, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q2 Molecular Biology

14.

Kiss, D. Z., Horváth, B., Hézső, T., Dienes, C., Kovács, Z. M., Topal, L., Szentandrássy, N., Almássy, J., Prorok, J., Virág, L., Bányász, T., Varró, A., Nánási, P. P., Magyar, J.: Late Na+ Current Is [Ca2+]i-Dependent in Canine Ventricular Myocytes.
Pharmaceuticals (Basel). 14 (11), 1142, (article identifier: 1142), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

15.

Hézső, T., Naveed, M., Dienes, C., Kiss, D. Z., Prorok, J., Árpádffy-Lovas, T., Varga, R., Fujii, E., Mercan, T., Topal, L., Kistamás, K., Szentandrássy, N., Almássy, J., Jost, N., Magyar, J., Bányász, T., Baczkó, I., Varró, A., Nánási, P. P., Virág, L., Horváth, B.: Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium.
Sci. Rep. 11, 9565, (article identifier: 9565), 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

16.

Jost, N., Christ, T., Magyar, J.: New Strategies for the Treatment of Atrial Fibrillation.
Pharmaceuticals (Basel). 14 (9), 926, (article identifier: 926), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

17.

Horváth, B., Hézső, T., Kiss, D. Z., Kistamás, K., Magyar, J., Nánási, P. P., Bányász, T.: Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.
Front. Pharmacol. 11, 1-17, (article identifier: 413), 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology

Q1 Pharmacology (medical)

18.

Horváth, B., Hézső, T., Szentandrássy, N., Kistamás, K., Árpádffy-Lovas, T., Varga, R., Gazdag, P., Veress, R., Dienes, C., Baranyai, D., Almássy, J., Virág, L., Nagy, N., Baczkó, I., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Late sodium current in human, canine and guinea pig ventricular myocardium.
J. Mol. Cell. Cardiol. 139, 14-23, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q2 Molecular Biology

19.

Kiss, D., Hézső, T., Kurtan, B., Veress, R., Baranyai, D., Kovács, Z., Dienes, C., Szentandrássy, N., Bányász, T., Magyar, J., Nánási, P. P., Horváth, B.: Regulation of the delayed rectifier potassium current during the adrenergic adaptation of cardiomyocytes.
Europace. 22 (Suppl_1), P938, (article identifier: 938), 2020.

doi DEA

20.

Horváth, B., Szentandrássy, N., Veress, R., Baranyai, D., Kistamás, K., Almássy, J., Tóth, A., Magyar, J., Bányász, T., Nánási, P. P.: Effect of the intracellular calcium concentration chelator BAPTA acetoxy-methylester on action potential duration in canine ventricular myocytes.
J. Physiol. Pharmacol. 69 (1), 99-107, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

21.

Veress, R., Baranyai, D., Hegyi, B., Kistamás, K., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Szentandrássy, N., Horváth, B.: Transient receptor potential melastatin 4 channel inhibitor 9-phenanthrol inhibits K+ but not Ca2+ currents in canine ventricular myocytes.
Can. J. Physiol. Pharmacol. 96 (10), 1022-1029, 2018.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

Q3 Physiology (medical)

22.

Nánási, P. P., Magyar, J., Varró, A., Ördög, B.: Beat-to-beat variability of cardiac action potential duration: underlying mechanism and clinical implications.
Can. J. Physiol. Pharmacol. 95 (10), 1230-1235, 2017.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q3 Physiology

Q3 Physiology (medical)

23.

Horváth, B., Szentandrássy, N., Veress, R., Almássy, J., Magyar, J., Bányász, T., Tóth, A., Papp, Z., Nánási, P. P.: Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.
Naunyn Schmiedebergs Arch. Pharmacol. 390 (2), 1239-1246, 2017.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

24.

Magyar, J., Kistamás, K., Váczi, K., Hegyi, B., Horváth, B., Bányász, T., Nánási, P. P., Szentandrássy, N.: Concept of relative variability of cardiac action potential duration and its test under various experimental conditions.
Gen. Physiol. Biophys. 35 (1), 55-62, 2016.

doi DEA

Journal metrics:

Q3 Biophysics

Q3 Medicine (miscellaneous)

Q4 Physiology

25.

Szentandrássy, N., Horváth, B., Váczi, K., Kistamás, K., Masuda, L., Magyar, J., Bányász, T., Papp, Z., Nánási, P. P.: Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes.
J. Physiol. Pharmacol. 67 (4), 483-489, 2016.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Physiology

Division of Sports and Space Physiology

Publication list